Specialists from the Privolzhsky Research Medical University have presented a new medical solution and patented it in the Eurasian Patent Office.
This solution will be helpful in the treatment of osteopenia, a bone density disorder associated with an increased risk of bone fracture. Osteopenia most often occurs in patients with osteoporosis or spinal neoplasms, leading to disability. Reconstructive spine surgery employing bone cement, which improves bone strength and bearing capacity, is one of the treatments.
Specialists from the Privolzhsky University have developed an advanced bone cement consisting of two special components. Their combination produces a highly viscous substance that hardens over a certain period of time. This is bone cement. The doctor can inject it through a cannula needle into the affected vertebral body. Most importantly, unlike its analogues, this bone cement is radiopaque. This means that even during surgery, the X-ray can show how the substance has been applied and whether it has been distributed properly. Also, the new bone cement is highly viscous, has a moderate thermal effect, biocompatibility, and sufficient biomechanical strength in the solid phase. All these features make it better than its analogues.
